Paul Wadwa, MD
Pediatric Endocrinology
Locations
Practice Locations
Barbara Davis Center for Diabetes Pediatric Clinic - CU Anschutz Medical Campus
303-724-2323
Children's Colorado Health Pavilion
Aurora
720-777-1234
Children's Hospital Colorado Anschutz Medical Campus
Aurora
720-777-1234
Provider Expertise
Clinical Interest for Patients
Type 1 Diabetes, Clinical trials in type 1 diabetes, Telemedicine, artificial pancreas technology
Specialties
- Pediatric Endocrinology
Conditions & Treatments
-
Child and Teen Health
Juvenile Diabetes
Education & Training
Medical Schools
MD, Northwestern University The Feinberg School of Medicine (1996)
Undergraduate Schools
BS, Northwestern University (IL) (1992)
Internships
Nationwide Children's Hospital/Ohio State University Program (1997)
Residency Program
Nationwide Children's Hospital/Ohio State University Program (2000)
Fellowships
Cincinnati Children's Hospital Medical Center Program (2003)
Professional Memberships
American Diabetes Association, Member
International Society for Pediatric and Adolescent Diabetes, Member
Research & Grants
Research Interests for Patients
My primary research focus is on the development of the artificial pancreas for patients with type 1 diabetes. I am involved in many clinical research studies with the goal of advancing artificial pancreas technology. I am also engaged in clinical trials of new therapeutic agents as well as research describing the effects of a clinical telemedicine program on diabetes control for youth with type 1 diabetes. My hope is that the research I am involved with will greatly improve the tools available to optimize control and reduce the burden of diabetes for patients locally and beyond.
information for referring providers
Referral Contact Phone
(303) 724-2323
Referral Contact Fax
303-724-6779
Clinical Interests for Referring Providers
Type 1 Diabetes, Clinical trials in type 1 diabetes, Telemedicine, Artificial pancreas technology
Research Interest for Referring Providers
Dr. Wadwa’s research primarily focuses on the development of the artificial pancreas. He is engaged as a site PI and as a co-investigator for several NIH-sponsored and industry- sponsored clinical research studies with the goal of advancing artificial pancreas technology. Dr. Wadwa is also engaged in clinical trials of new therapeutic agents as well as research describing the effects of a clinical telemedicine program on glycemic control in pediatric type 1 diabetes patients.
